Page 7 - Vaccine

Vax milestone and a K-shaped problem

Lower-income groups will be far more vulnerable in the Third Wave, whenever that arrives

1 billion doses: How India's Covid vaccine campaign compares to others

Most populous states may decide pace going forward

Vaccine makers meet WTO D-G, flag excess capacity of Covid-19 jabs

Some manufacturers also said that the regulatory approval framework for Covid-19 vaccines in other nations also takes a substantial amount of time

The next level

Vaccination programme still has a long way to go

Vaccine working on new variants next challenge: SII CEO Adar Poonawalla

'We are delivering 220 million doses a month, and almost everything is being consumed', said Poonawalla

Covid-19 pandemic: Vaccinating children not a priority for now, say experts

They say mRNA vaccines could offer best protection for vulnerable children

How Gennova is developing India's first indigenous mRNA Covid-19 shot

Where Gennova scores is that it has achieved to crack the stringent sub-zero temperature requirements

Moderna and Johnson & Johnson support Covid-19 vaccine boosters

The FDA panel will meet on Thursday and Friday to weigh the evidence for booster doses

Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years

First Covid-19 vaccine in the world for children this young

Expert panel allows adolescent trials of J&J vaccine with riders

SEC asks J&J to monitor adverse events closely for next three months

Vaccine diplomacy and drama

India transferred five million jabs to Britain in need

75 countries add to calls for global solidarity for vaccine equity

The pandemic knows no borders, the only solution lies in global solidarity, unity and multilateral cooperation, said the countries in a joint statement.

Kerala Health Minister launches pneumococcal conjugate vaccine for infants

Kerala Health Minister Veena George launched the pneumococcal conjugate vaccine for infants as part of the state's Universal Immunisation Programme at the Government Women And Children's Hospital

MSD launches gender-neutral HPV vaccine in India, licences Covid jab

HPV infections are one of the leading causes of cervical cancer in women

New AstraZeneca tie-up to explore vaccine tech for cancer, heart disease

An Imperial College London start-up has tied up with British-Swedish biopharmaceutical major AstraZeneca to explore the therapeutic uses of its vaccine technology

Sanofi drops plans for messenger RNA vaccine against coronavirus

French drugmaker Sanofi said Tuesday it was shelving plans for a Covid-19 vaccine based on messenger RNA despite positive results from early stage testing

Home Covid-19 vaccinations for those with restricted mobility: Govt

The health ministry has also cautioned that "open vial policy" is not acceptable for Covid vaccines

66% adults in India have got first Covid-19 vaccine dose: Health ministry

Only 6% of vaccinations done in private hospitals since May: Health ministry

Covid-19 vaccine: AstraZeneca to develop Imperial's new RNA technology

Under the deal, VaxEquity, a start-up founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are met

EU regulator to decide on Pfizer booster dose at the start of October

Pfizer declined to comment, while BioNTech was not available for comment